SCHEMBL32669657

SCHEMBL32669657

Cc1cc(/C(O)=C(\C#N)C(=O)N(C)CC#Cc2ccccc2Cl)cc([N+](=O)[O-])c1O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 7/20 0.50
COMT P21964 6/20 0.50
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
ABCC3 O15438 1/20 0.34
ABCC4 O15439 1/20 0.34
ABCB11 O95342 1/20 0.34
CYP2C9 P11712 1/20 0.34
KMT2A Q03164 1/20 0.34
GPR35 Q9HC97 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MITF O75030 1/20 0.34
S1PR4 O95977 1/20 0.34
S1PR1 P21453 1/20 0.34
CTSB P07858 1/20 0.33
VCAM1 P19320 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669920 0.93 FTO (0.52) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669955 0.92 FTO (0.60) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669980 0.92 FTO (0.52) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669651 0.89 FTO (0.48) FTOCOMTLMNAMEN1KMT2A
SCHEMBL32669609 0.88 FTO (0.47) FTOCOMTLMNAMEN1KMT2A
SCHEMBL32669522 0.86 FTO (0.59) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32670128 0.84 FTO (0.61) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669862 0.83 FTO (0.60) FTOCOMTLMNAMEN1ABCC3
SCHEMBL32669774 0.83 FTO (0.47) FTOCOMTLMNAMEN1KMT2A
SCHEMBL32669728 0.83 FTO (0.59) FTOCOMTLMNAMEN1ABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885LMNA 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.